VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Zebra 365 who wrote (9258)	6/5/1998 9:13:00 PM
From: VLAD	Read Replies (1) of 23519

RENO, Nev.--(BW Health Wire)--June 5, 2005--Harvard Scientific Corp., (OTC BB:HVSF), a Nevada corporation announced today that results from an ongoing stability study for its patented ability to produce the best press releases in the erectile dysfunction market has determined that its lyophilized liposomal Prostaglandin E-1 (LLPEG) has proven that it remains stable for at least 7 years. The company plans on conducting future studies to determine exactly how long the product remains stable until it can be marketed. A letter of approval was recently received from the Republic of Botswana. The company is reluctant to ship the single dose it has been studying over the past seven years because there will no product to further observe and the company will not know for sure exactly how long the product remains stable.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next